Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM).

Hyunkyung ParkJa Min Byun Sung Soo YoonYoungil KohDong-Yeop ShinJunshik HongInho Kim

Published in: Journal of clinical medicine (2020)

AlloSCT can still be implemented as effective salvage option in the treatment of relapsed/refractory high-risk MM. The optimal timing of alloSCT remains to be determined.

Keyphrases

stem cell transplantation
multiple myeloma
high dose
acute lymphoblastic leukemia
acute myeloid leukemia
diffuse large b cell lymphoma
hodgkin lymphoma
bone marrow
low dose